When was REYNDERS PHARMACEUTICAL LABELS founded?

REYNDERS PHARMACEUTICAL LABELS was founded on 15 Jan 1991, making it 35 years old.

Is REYNDERS PHARMACEUTICAL LABELS still active?

Yes, REYNDERS PHARMACEUTICAL LABELS is currently active.

What does REYNDERS PHARMACEUTICAL LABELS do?

REYNDERS PHARMACEUTICAL LABELS's registered main activities are Manufacture of other articles of paper and paperboard, Other printing, and Folding, assembling, stapling, binding, gluing, guillotining, gold plating of printed sheets to be inserted in books, leaflets, periodicals, catalogues, etc..

Where is REYNDERS PHARMACEUTICAL LABELS registered?

REYNDERS PHARMACEUTICAL LABELS's registered address is Nijverheidsstraat 15, 2530 Boechout, Belgium.

How many employees does REYNDERS PHARMACEUTICAL LABELS have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), REYNDERS PHARMACEUTICAL LABELS reported 130 full-time equivalent employees.

What is REYNDERS PHARMACEUTICAL LABELS's annual turnover?

REYNDERS PHARMACEUTICAL LABELS's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €42,365,753.

Did REYNDERS PHARMACEUTICAL LABELS make a profit or a loss?

REYNDERS PHARMACEUTICAL LABELS's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €9,189,270.

When did REYNDERS PHARMACEUTICAL LABELS last file annual accounts?

REYNDERS PHARMACEUTICAL LABELS's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is REYNDERS PHARMACEUTICAL LABELS B Corp certified?

We have no B Corp certification on file for REYNDERS PHARMACEUTICAL LABELS.

Does REYNDERS PHARMACEUTICAL LABELS hold Fairtrade certification?

No, REYNDERS PHARMACEUTICAL LABELS does not currently hold Fairtrade certification.

REYNDERS PHARMACEUTICAL LABELS

BE 0443.025.922

Copied!

NV/SA

Status

Active

Founded

15 Jan 1991

Size

Medium · 130 FTE

Age

35 yrs

Main activity

Manufacture of other articles of paper and paperboard

Activities

3 activities

Manufacture of other articles of paper and paperboardOther printingFolding, assembling, stapling, binding, gluing, guillotining, gold plating of printed sheets to be inserted in books, leaflets, periodicals, catalogues, etc.

Financials

Turnover2025

€42.4M+0.3%

Profit / Loss2025

€9.2M-7.7%

Equity2025

€15.1M+26.8%

2025	2024	2023	2022
€42,365,753+0.3%	€42,246,472+7.7%	€39,213,527+6.5%	€36,810,236
€9,189,270-7.7%	€9,954,986+2.3%	€9,734,159+14.9%	€8,474,047
€15,098,332+26.8%	€11,909,063+40.5%	€8,479,077-60.4%	€21,388,558
€13,306,689-19%	€16,435,177-1.7%	€16,711,892+292.4%	€4,258,407
€11,096,305+4.4%	€10,625,158+27.3%	€8,349,797-11.1%	€9,395,661
130+6.7%	121.8+3%	118.2+4.1%	113.5
€325,890-6%	€346,851+4.6%	€331,756+2.3%	€324,319

Frequently asked questions

01What is REYNDERS PHARMACEUTICAL LABELS's official registered name?

REYNDERS PHARMACEUTICAL LABELS.

02What is REYNDERS PHARMACEUTICAL LABELS's enterprise number (VAT number)?

BE 0443.025.922.

03What is REYNDERS PHARMACEUTICAL LABELS's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€42,365,753+0.3%	€42,246,472+7.7%	€39,213,527+6.5%	€36,810,236
	€9,779,071+10.3%	€8,864,553+7.1%	€8,279,365+11.1%	€7,452,250
	€12,046,541-7.6%	€13,042,899+3%	€12,665,818+17.4%	€10,787,422
	€13,283,003-5.6%	€14,068,476+8.8%	€12,936,257+2.3%	€12,645,434
	€9,189,270-7.7%	€9,954,986+2.3%	€9,734,159+14.9%	€8,474,047
	€661,122+396.8%	€133,079-74.4%	€519,353+134.3%	€221,694
Profitability
	31.4%-5.8%	33.3%+0.9%	33.0%-4%	34.4%
	21.7%-7.9%	23.6%-5.1%	24.8%+7.8%	23.0%
	60.9%-27.2%	83.6%-27.2%	114.8%+189.8%	39.6%
	32.4%-7.9%	35.1%-9.1%	38.6%+17%	33.0%
Solvency
	€28,405,021+0.2%	€28,344,239+12.5%	€25,190,969-1.8%	€25,646,964
	€5,390,704+14.1%	€4,723,610-16%	€5,624,869+109%	€2,691,713
	€1,0000%	€1,0000%	€1,0000%	€1,000
	€15,098,332+26.8%	€11,909,063+40.5%	€8,479,077-60.4%	€21,388,558
	53.2%+26.5%	42.0%+24.8%	33.7%-59.6%	83.4%
	€13,306,689-19%	€16,435,177-1.7%	€16,711,892+292.4%	€4,258,407
	0.88-36.1%	1.38-30%	1.97+890%	0.20
	90.31+72.5%	52.37-72.1%	188.03	—
Liquidity
	€11,096,305+4.4%	€10,625,158+27.3%	€8,349,797-11.1%	€9,395,661
	€2,986,316-17.3%	€3,612,907+2.6%	€3,521,559-15.5%	€4,168,580
	€8,133,197+3%	€7,900,252+14.1%	€6,923,129-19.3%	€8,580,911
	€1,219,553-23.6%	€1,595,739-13.6%	€1,847,925+46.9%	€1,258,198
	€12,515,885-20.4%	€15,721,912-0.7%	€15,834,594+364.2%	€3,410,993
	0.90+13.3%	0.79+17.8%	0.67-78.9%	3.18
	€9,706,629+35.1%	€7,184,453+151.8%	€2,853,208-84.7%	€18,695,845
Efficiency
	70 days+2.7%	68 days+5.9%	64 days-24.3%	85 days
	23 days-21.6%	29 days-20.5%	36 days+39.1%	26 days
	75 days-14.4%	87 days-1.5%	89 days-21.3%	113 days
	4.41+4.3%	4.23+12.5%	3.76+1.6%	3.70
Profit appropriation
	€6,000,000-8%	€6,525,000-71%	€22,500,000+733.3%	€2,700,000
	€14,723,332+27.7%	€11,534,063+42.3%	€8,104,077-61.4%	€21,013,558

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€42,365,753+0.3%	€42,246,472+7.7%	€39,213,527+6.5%	€36,810,236
	€9,779,071+10.3%	€8,864,553+7.1%	€8,279,365+11.1%	€7,452,250
	€12,046,541-7.6%	€13,042,899+3%	€12,665,818+17.4%	€10,787,422
	€13,283,003-5.6%	€14,068,476+8.8%	€12,936,257+2.3%	€12,645,434
	€9,189,270-7.7%	€9,954,986+2.3%	€9,734,159+14.9%	€8,474,047
	€661,122+396.8%	€133,079-74.4%	€519,353+134.3%	€221,694
Profitability
	31.4%-5.8%	33.3%+0.9%	33.0%-4%	34.4%
	21.7%-7.9%	23.6%-5.1%	24.8%+7.8%	23.0%
	60.9%-27.2%	83.6%-27.2%	114.8%+189.8%	39.6%
	32.4%-7.9%	35.1%-9.1%	38.6%+17%	33.0%
Solvency
	€28,405,021+0.2%	€28,344,239+12.5%	€25,190,969-1.8%	€25,646,964
	€5,390,704+14.1%	€4,723,610-16%	€5,624,869+109%	€2,691,713
	€1,0000%	€1,0000%	€1,0000%	€1,000
	€15,098,332+26.8%	€11,909,063+40.5%	€8,479,077-60.4%	€21,388,558
	53.2%+26.5%	42.0%+24.8%	33.7%-59.6%	83.4%
	€13,306,689-19%	€16,435,177-1.7%	€16,711,892+292.4%	€4,258,407
	0.88-36.1%	1.38-30%	1.97+890%	0.20
	90.31+72.5%	52.37-72.1%	188.03	—
Liquidity
	€11,096,305+4.4%	€10,625,158+27.3%	€8,349,797-11.1%	€9,395,661
	€2,986,316-17.3%	€3,612,907+2.6%	€3,521,559-15.5%	€4,168,580
	€8,133,197+3%	€7,900,252+14.1%	€6,923,129-19.3%	€8,580,911
	€1,219,553-23.6%	€1,595,739-13.6%	€1,847,925+46.9%	€1,258,198
	€12,515,885-20.4%	€15,721,912-0.7%	€15,834,594+364.2%	€3,410,993
	0.90+13.3%	0.79+17.8%	0.67-78.9%	3.18
	€9,706,629+35.1%	€7,184,453+151.8%	€2,853,208-84.7%	€18,695,845
Efficiency
	70 days+2.7%	68 days+5.9%	64 days-24.3%	85 days
	23 days-21.6%	29 days-20.5%	36 days+39.1%	26 days
	75 days-14.4%	87 days-1.5%	89 days-21.3%	113 days
	4.41+4.3%	4.23+12.5%	3.76+1.6%	3.70
Profit appropriation
	€6,000,000-8%	€6,525,000-71%	€22,500,000+733.3%	€2,700,000
	€14,723,332+27.7%	€11,534,063+42.3%	€8,104,077-61.4%	€21,013,558

2025

2024

2023

2022

Income statement

€42,365,753+0.3%

€42,246,472+7.7%

€39,213,527+6.5%

€36,810,236

€9,779,071+10.3%

€8,864,553+7.1%

€8,279,365+11.1%

€7,452,250

€12,046,541-7.6%

€13,042,899+3%

€12,665,818+17.4%

€10,787,422

€13,283,003-5.6%

€14,068,476+8.8%

€12,936,257+2.3%

€12,645,434

€9,189,270-7.7%

€9,954,986+2.3%

€9,734,159+14.9%

€8,474,047

€661,122+396.8%

€133,079-74.4%

€519,353+134.3%

€221,694

Profitability

31.4%-5.8%

33.3%+0.9%

33.0%-4%

34.4%

21.7%-7.9%

23.6%-5.1%

24.8%+7.8%

23.0%

60.9%-27.2%

83.6%-27.2%

114.8%+189.8%

39.6%

32.4%-7.9%

35.1%-9.1%

38.6%+17%

33.0%

Solvency

€28,405,021+0.2%

€28,344,239+12.5%

€25,190,969-1.8%

€25,646,964

€5,390,704+14.1%

€4,723,610-16%

€5,624,869+109%

€2,691,713

€1,0000%

€1,000

€15,098,332+26.8%

€11,909,063+40.5%

€8,479,077-60.4%

€21,388,558

53.2%+26.5%

42.0%+24.8%

33.7%-59.6%

83.4%

€13,306,689-19%

€16,435,177-1.7%

€16,711,892+292.4%

€4,258,407

0.88-36.1%

1.38-30%

1.97+890%

0.20

90.31+72.5%

52.37-72.1%

188.03

—

Liquidity

€11,096,305+4.4%

€10,625,158+27.3%

€8,349,797-11.1%

€9,395,661

€2,986,316-17.3%

€3,612,907+2.6%

€3,521,559-15.5%

€4,168,580

€8,133,197+3%

€7,900,252+14.1%

€6,923,129-19.3%

€8,580,911

€1,219,553-23.6%

€1,595,739-13.6%

€1,847,925+46.9%

€1,258,198

€12,515,885-20.4%

€15,721,912-0.7%

€15,834,594+364.2%

€3,410,993

0.90+13.3%

0.79+17.8%

0.67-78.9%

3.18

€9,706,629+35.1%

€7,184,453+151.8%

€2,853,208-84.7%

€18,695,845

Efficiency

70 days+2.7%

68 days+5.9%

64 days-24.3%

85 days

23 days-21.6%

29 days-20.5%

36 days+39.1%

26 days

75 days-14.4%

87 days-1.5%

89 days-21.3%

113 days

4.41+4.3%

4.23+12.5%

3.76+1.6%

3.70

Profit appropriation

€6,000,000-8%

€6,525,000-71%

€22,500,000+733.3%

€2,700,000

€14,723,332+27.7%

€11,534,063+42.3%

€8,104,077-61.4%

€21,013,558

REYNDERS PHARMACEUTICAL LABELS

Activities

Financials

Frequently asked questions

All locations

All locations